(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

NUCLEODOXINA

This trademark appears in the official INPI history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

Registro ExtintoType: WordOffice: Brazil

Quick snapshot

NUCLEODOXINA

ST13

BR500000004501411

Class

5

Filing

004501411

Registration

004501411

Progress at the INPI

  1. Filing06/09/65
  2. Publication
  3. Examination
  4. Allowance
  5. Grant06/06/72
  6. Terminated03/02/93

The registration was granted on 06/06/1972 and later terminated. The mark is no longer protected.

Check whether this name is available

Latest action published by the INPI: 03/02/1993. We update with every new RPI gazette, published weekly.

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

INPI status

Registro Extinto

Case type

Application and registration

Recorded events

1

Latest update

03/02/1993

Trademark type

Word

Nice classes

5

Filing date

06/09/1965

Registration date

06/06/1972

Expiration date

06/06/1992

Complete case details

Structured fields from the responsible authority and the official record.

Nature

De Produto

Responsible office

Brazil

Owner type

PESSOA JURÍDICA

Owner location

SP, BR

Holders and representatives

Holders

LABORATORIOS BALDACCI S A

Representatives

No representative data.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicamentos que atuam no sistema nervoso central e periférico

Publications

History of INPI decisions and trademark events.

1 publications found

700

Registro EXTINTO, com base na norma legal indicada.

ITEM 1 DO ART. 93 DO CPI * INT. GUSTAVO STIEF

RPI 1161

03/02/1993

LABORATORIOS BALDACCI S A also protects technology and design at the INPI

1 patent application under the same owner.

Related trademarks

Similar trademarks

Continuous trademark protection

Get notified about every new filing that threatens NUCLEODOXINA or your mark.

Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.